Clinical utility of N-terminal pro-B-type natriuretic peptide for risk stratification of patients with acute decompensated heart failure. Derivation and validation of the ADHF/NT-proBNP risk score

International Journal of Cardiology

Volumn 168, Issue 3, 2013, Pages 2120-2126

  Scrutinio, Domenico ^a   Ammirati, Enrico ^b   Guida, Pietro ^a   Passantino, Andrea ^a   Raimondo, Rosa ^a   Guida, Valentina ^b   Braga, Simona Sarzi ^a   Pedretti, Roberto F E ^a   Lagioia, Rocco ^a   Frigerio, Maria ^b   Catanzaro, Raffaella ^a   Oliva, Fabrizio ^b  

^a IRCCS   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

Acute heart failure; N terminal pro B type natriuretic peptide; Prognosis; Risk stratification

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; HEMOGLOBIN; INOTROPIC AGENT; SODIUM; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ACUTE CORONARY SYNDROME; ACUTE HEART FAILURE; ADULT; AGED; ANGINA PECTORIS; ARTICLE; CALIBRATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE EJECTION FRACTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SCORING SYSTEM; SODIUM BLOOD LEVEL; TRICUSPID VALVE REGURGITATION; VALIDATION PROCESS; ACUTE DISEASE; BLOOD; CAUSE OF DEATH; COMPARATIVE STUDY; EPIDEMIOLOGY; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; INCIDENCE; ITALY; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; RISK ASSESSMENT; RISK FACTOR; TIME; TRENDS; VALIDATION STUDY; VERY ELDERLY;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; INCIDENCE; ITALY; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 84885663079     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.01.005     Document Type: Article

References (54)

1. M. Jessup, W.T. Abraham, and D.E. Casey 2009 focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the International Society for Heart and Lung Transplantation Circulation 119 2009 1977 2016
2. A.P. Maggioni, U. Dahlström, and G. Filippatos EURObservational research programme: the Heart Failure Pilot Survey (ESC-HF Pilot) Eur J Heart Fail 12 2010 1076 1084
3. L. Tavazzi, A.P. Maggioni, and D. Lucci Nationwide survey on acute heart failure in cardiology ward services in Italy Eur Heart J 27 2006 1207 1215
4. L.M. Yamokoski, V. Hasselblad, and D.K. Moser Prediction of rehospitalization and death in severe heart failure by physicians and nurses of the ESCAPE trial J Card Fail 13 2007 8 13
5. D.S. Lee, J.V. Tu, and D.N. Juurlink Risk-treatment mismatch in the pharmacotherapy of heart failure JAMA 294 2005 1240 1247
6. S.M. Gharacholou, A.S. Hellkamp, and A.F. Hernandez Use and predictors of heart failure disease management referral in patients hospitalized with heart failure: Insights from the Get With the Guidelines Program J Card Fail 17 2011 431 439
7. E.S. Ketchum, and W.C. Levy Multivariate risk scores and patients outcomes in advanced heart failure Congest Heart Fail 17 2011 205 212
8. G.C. Fonarow, W.F. Peacock, C.O. Phillips, and M.M. Givertz Lopatin M for the ADHERE Scientific Advisory Committee and Investigators. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure J Am Coll Cardiol 49 2007 1943 1950
9. J.L. Januzzi, R. van Kimmenade, and J. Lainhbury NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients. The International Collaborative of NT-proBNP Study Eur Heart J 27 2006 330 337
10. R. Pfister, H. Diedrichs, and A. Schiedermair Prognostic impact of NT-proBNP and renal function in comparison to contemporary multi-marker risk scores in heart failure patients Eur J Heart Fail 10 2008 315 320
11. K. Thygesen, J. Mair, and C. Mueller Recommendations for the use of natriuretic peptides in acute cardiac care. A position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care Eur Heart J 33 2012 2001 2006
12. D. Scrutinio, P. Guida, and A. Passantino Amino-terminal pro-B-type natriuretic peptide for risk prediction in acute decompensated heart failure Congest Heart Fail 18 2012 308 314
13. D.S. Lee, P.C. Austin, and J.L. Rouleau Predicting mortality among patients hospitalized for heart failure. Derivation and validation of a clinical model JAMA 290 2003 2581 2587
14. N.R. Cook, and P.M. Ridker Advances in measuring the effect of individual predictor of cardiovascular risk: the role of reclassification measures Ann Intern Med 150 2009 795 802
15. H. Janes, M.S. Pepe, and W. Gu Assessing the value of risk predictions by using risk stratification tables Ann Intern Med 149 2008 751 760
16. E.W. Steyerberg, A.J. Vickers, and N.R. Cook Assessing the performance of prediction models. A framework of traditional and novel measures Epidemiology 21 2010 128 138
17. F.J. Harrell Regression modeling strategies 2001 Springer-Verlag New York, NY
18. M.J. Pencina, and R.B. D'Agostino Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation Stat Med 23 2004 2109 2123
19. D.W. Hosmer, and S. Lemeshow Applied logistic regression 2nd ed. 2000 John Wiley & Sons Inc. New York, NY
20. M.J. Pencina, R.B. D'Agostino, R.B. D'Agostino Jr., and R.S. Vasan Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2008 157 172
21. L. Klein, B.M. Massie, and J.D. Leimberger Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the outcomes of a prospective trial of intravenous Milrinone for exacerbations of chronic heart failure (OPTIME-CHF) Circ Heart Fail 1 2008 25 33
22. A.S. Go, J. Yang, and L.M. Ackerson Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic heart Failure: outcomes and resource utilization (ANCHOR) study Circulation 113 2006 2713 2723
23. V.-P. Harjola, F. Follath, and M.S. Nieminen Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failure Eur J Heart Fail 12 2010 239 248
24. D.S. Lee, P.C. Austin, J.L. Rouleau, P.P. Liu, D. Naimark, and J.V. Tu Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model JAMA 290 2003 2581 2587
25. A.A. Mohammed, R.R.J. van Kimmenade, and M. Richards Hyponatremia, natriuretic peptides, and outcomes in acutely decompensated heart failure: results from the International Collaborative of NT-proBNP Study Circ Heart Fail 3 2010 354 361
26. H.F. Groenveld, J.L. Januzzi, and K. Damman Anemia and mortality in heart failure patients: a systematic review and meta-analysis J Am Coll Cardiol 52 2008 818 827
27. F. Oliva, A. Mortara, and G. Cacciatore Acute heart failure patient profiles, management and in-hospital outcome: results of the Italian Registry on Heart Failure Outcome Eur J Heart Fail 14 2012 1208 1217
28. A. Rassi Jr., A. Rassi, and W.C. Little Development and validation of a risk score for predicting death in Chagas' heart disease N Engl J Med 355 2006 799 808
29. E.W. Steyerberg, G.J.J.M. Borsboom, H.C. van Houwelingen, M.J.C. Eijkemans, and J.D.F. Habbema Validation and updating of predictive logistic regression models: a study on sample size and shrinkage Stat Med 23 2004 2567 2586
30. M.J. Pencina, R.B. D'Agostino Sr., and E.W. Steyerberg Extensions of the net reclassification improvement calculations to measure usefulness of new biomarkers Stat Med 30 2011 11 21
31. D.G. Altman, and P. Royston What do we mean by validating a prognostic model? Stat Med 19 2000 453 473
32. M.S. Pepe, and H. Janes Commentary: reporting standards are needed for evaluation of risk reclassification Int J Epidemiol 40 2011 1106 1108
33. J. Hilden, and T.A. Gerds Evaluating the impact of novel biomarkers: do not rely on IDI and NRI ttps://ifsv.sund.ku.dk/biostat/biostat-annualreport/ images/6/64/Research-Report-12-08.pdf [Accessed on October 20, 2012]
34. I. Tzoulaki, G. Liberopoulos, and J.P.A. Ioannidis Use of reclassification for assessment of improved prediction: an empirical evaluation Int J Epidemiol 40 2011 1094 1105
35. M.S. Pepe Problems with risk reclassification methods for evaluating prediction models Am J Epidemiol 173 2011 1327 1335
36. J.T. Wang Assessing the role of circulating, genetic, and imaging biomarkers in cardiovascular risk prediction Circulation 123 2011 551 565
37. K. McGeechan, P. Macaskill, L. Irwig, G. Liew, and T.Y. Wong Assessing new biomarkers and predictive models for use in clinical practice: a clinician's guide Arch Intern Med 168 2008 2304 2310
38. W.C. Levy, K.L. Lee, and A.S. Hellkamp Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population Circulation 120 2009 835 842
39. R.M. Cubbon, C.P. Gale, and L.C. Kearney Changing characteristics and mode of death associated with chronic heart failure caused by left ventricular systolic dysfunction. A study across therapeutic eras Circ Heart Fail 4 2011 396 403
40. The Evaluation of VAD InterVEntion Before Inotropic Therapy (REVIVE-IT). ClinicalTrials Identifier: NCT01369407) www.cinicaltrials.gov [accessed on November 8, 2012]
41. J.T. Baldwin, and L.M. Douglas NHLBI's program for VAD intervention for moderately advanced heart failure. The REVIVE-IT pilot trial J Card Fail 16 2010 855 858
42. A.P. Kalogeropoulos, V.V. Georgiopoulou, and G. Giamouzis Utility of the Seattle Heart Failure Model in patients with advanced heart failure J Am Coll Cardiol 53 2009 334 342
43. C.M. O'Connor, V. Hasselblad, and R.H. Mehta Triage after hospitalization with advanced heart failure J Am Coll Cardiol 55 2010 872 878
44. R.D. Kociol, J.R. Horton, and G.C. Fonarow Admission, discharge, or change in BNP and long-term outcomes: data from OPTIMIZE-HF linked to medicare claims Circ Heart Fail 4 2011 628 636
45. M. Komajda, O. Hanon, and M. Hochadel Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II Eur Heart J 30 2009 478 486
46. Heart Failure Society of America HFSA 2010 Comprehensive Heart Failure Practice Guideline J Card Fail 16 2010 e1 e194
47. G.C. Fonarow, W.T. Abraham, and N.M. Albert Association between performance measures and clinical outcome for patients hospitalized for heart failure JAMA 297 2007 61 70
48. P.N. Peterson, J.S. Rumsfeld, and L. Liang Treatment and risk in heart failure: gaps in evidence or quality? Circ Cardiovasc Qual Outcomes 3 2010 309 315
49. L.A. Savard, D.R. Thompson, and A.M. Clark A meta-review of evidence of heart failure disease management programs: the challenges of describing and synthesizing evidence on complex interventions Trials 12 2011 194
50. A.T. Yan, R.T. Yan, and T. Huynh Understanding physicians' risk stratification of acute coronary syndromes: insights from the Canadian ACS 2 Registry Arch Intern Med 169 2009 372 378
51. H. Prasad, J. Sra, W.C. Levy, and D.D. Stapleton Influence of predictive modeling in implementing optimal heart failure therapy Am J Med Sci 341 2011 185 190
52. C.M. O'Connor, A.B. Miller, and J.E.A. Blair Causes of death and rehospitalizations in patients hospitalized with worsening heart failure and reduced left ventricular function: results from efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan (EVEREST) program Am Heart J 159 2010 841 849
53. D. Scrutinio, A. Passantino, R. Catanzaro, and P. Guida Clinical utility of different estimates of renal function for predicting mortality in chronic heart failure Int J Cardiol 157 2012 24 30
54. L.A. Allen, L.W. Stevenson, and K.L. Grady Decision making in advanced heart failure. A scientific statement from the American Heart Association Circulation 125 2012 1928 1952